VANECK PHARMACEUTICAL ETF - USD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 87.11 USD | -0.34% |
|
+0.68% | +7.06% |
ETF Ratings
 |
Description
| US92189F6925 | |
|---|---|
| Total Expense Ratio | 0.35% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | MVIS US Listed Pharmaceutical 25 Net Total Return Index - USD |
Features and characteristics
| Jurisdiction | |
| Fund Structure | |
| Replication Method | |
| Replication Model | |
| Date of creation |
20/12/2011
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 28/03/2024 )
| AuM (EUR) | 503 M€ |
|---|---|
| AuM 1M | 475 M€ |
| AuM 3 months | 395 M€ |
| AuM 6 months | 407 M€ |
| AuM 12 months | 338 M€ |
